Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (41-50 of 315) with videos related to

Pageof 32
Sort By:
Journal of the National Cancer Institute|March 23, 2021
Pancreatic Cancer in Young Adults: Can Innovative Approaches Lead to Better Outcomes?Dana B Cardin, Cathy Eng
Cancers|August 23, 2020
Neoadjuvant Chemotherapy for Colon CancerMarc T. Roth, Cathy Eng
Expert Opinion on Pharmacotherapy|December 29, 2018
Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is requiredCathy Eng, Jane E Rogers
Drugs|August 4, 2017
Pharmacotherapy of Anal CancerJane E Rogers, Cathy Eng
Expert Opinion on Biological Therapy|March 25, 2021
BRAF V600E mutated metastatic colorectal cancer: current progress and future directionsAudrey E Kam, Cathy Eng
Expert Opinion on Biological Therapy|May 12, 2011
Cetuximab in the treatment of patients with colorectal cancerChristopher R Garrett, Cathy Eng
Expert Opinion on Investigational Drugs|November 2, 2018
Experimental and investigational drugs for the treatment of anal cancerAlexandre A Jacome, Cathy Eng
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal CanalVan K Morris, Cathy Eng
Journal of Experimental Pharmacology|November 18, 2020
Up-and-Coming Experimental Drug Options for Metastatic Colorectal CancerSarah K Cimino, Cathy Eng
Expert Opinion on Biological Therapy|October 24, 2019
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumabAlexandre A Jácome, Cathy Eng
Pageof 32

Showing results (41-50 of 315) with videos related to

Sort By:
Pageof 32
Journal of the National Cancer Institute|March 23, 2021
Pancreatic Cancer in Young Adults: Can Innovative Approaches Lead to Better Outcomes?Dana B Cardin, Cathy Eng
Cancers|August 23, 2020
Neoadjuvant Chemotherapy for Colon CancerMarc T. Roth, Cathy Eng
Expert Opinion on Pharmacotherapy|December 29, 2018
Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is requiredCathy Eng, Jane E Rogers
Drugs|August 4, 2017
Pharmacotherapy of Anal CancerJane E Rogers, Cathy Eng
Expert Opinion on Biological Therapy|March 25, 2021
BRAF V600E mutated metastatic colorectal cancer: current progress and future directionsAudrey E Kam, Cathy Eng
Expert Opinion on Biological Therapy|May 12, 2011
Cetuximab in the treatment of patients with colorectal cancerChristopher R Garrett, Cathy Eng
Expert Opinion on Investigational Drugs|November 2, 2018
Experimental and investigational drugs for the treatment of anal cancerAlexandre A Jacome, Cathy Eng
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal CanalVan K Morris, Cathy Eng
Journal of Experimental Pharmacology|November 18, 2020
Up-and-Coming Experimental Drug Options for Metastatic Colorectal CancerSarah K Cimino, Cathy Eng
Expert Opinion on Biological Therapy|October 24, 2019
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumabAlexandre A Jácome, Cathy Eng
Pageof 32